Gregory D Davis Insider Profile
4 Followers
Gregory D Davis, Head of Research & Technology at Sangamo Therapeutics, holds 115.28K shares in Sangamo Therapeutics (Ticker: SGMO). Most recently, Gregory D Davis Sold 69,827 shares of Sangamo Therapeutics on Apr 23, 2026 for an estimated value of $17.46K.
Gregory D Davis has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Gregory D Davis's holdings
Insider Roles
Head of Research & Technology
Roles that Gregory D Davis holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gregory D Davis
Gregory D Davis's Trading History
List of latest transactions for each holding click on a transaction to see Gregory D Davis's performance on stock
You May Also Like
Gregory D Davis insider profile FAQ
What is the percentage of profitable transactions made by Gregory D Davis?
The percentage of profitable transactions made by Gregory D Davis is ―.
What is the average return per transaction made by Gregory D Davis?
The average return per transaction made by Gregory D Davis is ―.
What stocks does Gregory D Davis hold?
Gregory D Davis holds: SGMO stocks.
What was Gregory D Davis’s latest transaction?
Gregory D Davis latest transaction was an Informative Sell of $17.46K.
What was Gregory D Davis's most profitable transaction?
Gregory D Davis’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gregory D Davis's role in Sangamo Therapeutics?
Gregory D Davis's role in Sangamo Therapeutics is Head of Research & Technology.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.